Hx Diagnostics
Stage
Series B | AliveTotal Raised
$7.82MLast Raised
$4.7M | 14 yrs agoMissing: Hx Diagnostics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Hx Diagnostics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Hx Diagnostics Frequently Asked Questions (FAQ)
Where is Hx Diagnostics's headquarters?
Hx Diagnostics's headquarters is located at 5980 Horton Street, Emeryville.
What is Hx Diagnostics's latest funding round?
Hx Diagnostics's latest funding round is Series B.
How much did Hx Diagnostics raise?
Hx Diagnostics raised a total of $7.82M.
Who are the investors of Hx Diagnostics?
Investors of Hx Diagnostics include Kleiner Perkins Caufield & Byers, Xiamen YST Biotech and Nanogen.
Who are Hx Diagnostics's competitors?
Competitors of Hx Diagnostics include Integrated Diagnostics, Oxford BioDynamics, Advanced Cell Diagnostics, Allegro Diagnostics, Cylex and 14 more.
Compare Hx Diagnostics to Competitors
ViralTest offers molecular-based diagnostics development for niche infectious diseases markets.
At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.
ProteoGenix offers maternal-fetal diagnostics
LabNow has developed the LabNow System to conduct healthcare-related diagnostics at the point-of-care.
Chemogen develops rapid diagnostic tests for infectious diseases, currently focused on TB
Lifelinelab s.r.l. started its activities in April 2003, thanks to the commitment of three managers coming from the ex Diagnostic Division Manufacturing Plant of Alfa Wassermann S.P.A. First step has been to secure raw materials, and equipment for R&D and Manufacturing of products and services in the field of Human in Vitro Diagnostics. nnnnnFirst diagnostic reagents were manufactured, in this site, over 40 years ago, through the bravery and the enterprising spirit of Prof. Balducci ex Managing Director of Virology Laboratory of "Istituto Superiore di Sanitu00e0". First products were based on tissue colture technology included a line of complement fixation antigens. Since then, the company developed methods and products, covering almost all the fields of Human in Vitro Diagnostics, from Clinical Chemistry to Immunochemistry. The mostly developed sector has been that of Infectious Diseases with particular regard to Viral pathologies. Most products have been developed using biological raw materials derived from in house, in vivo or in vitro, productions. Nowadays the company aims to face and develop markets with consolidate and emerging technologies such as Microarrays using a chemistry patented and designed to covalently bind either Protein or Nucleic acids which aims to allow the development of extremely sophisticated analysis in the emerging applications of proteomics and genomics.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.